Japanese patients with vitiligo experienced lower quality of life and higher levels of anxiety and depression, especially when the disease affected their social life or had relapsed, according to a ...
Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with ...
In another first, Sandoz launched in November 2025 the first FDA-approved biosimilar of Tysabri (natalizumab). Tyruko (natalizumab-sztn) is used to treat adult patients with relapsing multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback